Search Results for: PLATFORM TECHNOLOGY The 3DNA Platform
Articles
November 7, 2016
PLATFORM TECHNOLOGY - The 3DNA® Platform for Targeted Drug Delivery November 7, 2016
Robert C. Getts, PhD, and Jessica Bowers review how the 3DNA platform is composed entirely of noncoding DNA assembled through the sequential hybridization of single strands of DNA into a network of double-stranded nucleic acid having a controlled architecture, and multiple attachment sites for drug and targeting molecules.
October 5, 2015
Genisphere Closes $4 Million for Expansion of 3DNA Targeted Drug Delivery Platform October 5, 2015
Genisphere LLC recently announced it has closed a $4-million equity round. This round of fundraising will extend and expand development...
October 24, 2017
Genisphere Pursues Neurotherapeutics Under Collaboration Agreement With Inserm October 24, 2017
Genisphere LLC has signed a collaborative research agreement with The Institut national de la santé et de la recherche médicale...
April 26, 2017
Genisphere Begins Collaborative & Sponsored Research Program With the University of Maryland April 26, 2017
Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University...
April 26, 2017
Genisphere Begins Collaborative & Sponsored Research Program With the University of Maryland April 26, 2017
Genisphere LLC, provider of the 3DNA® drug delivery platform, has signed a collaborative and sponsored research agreement with the University...
June 6, 2016
Genisphere Signs Collaborative Research, Option to License Agreement With MedImmune June 6, 2016
Genisphere LLC recently announced it has executed a collaborative research and option to license agreement with MedImmune, the global biologics...
March 28, 2016
Genisphere Enters Collaborative Nanotherapeutics Research Agreement March 28, 2016
Genisphere LLC has signed a collaborative research agreement with the University of Pennsylvania to study targeted nanotherapeutics in cancer treatment....
August 20, 2013
MultiCell Technologies & Genisphere Evaluate Targeted Delivery of MCT-485 for Cancer August 20, 2013
MultiCell Technologies, Inc. and Genisphere LLC will collaborate on the development of targeted MCT-485 nanoparticle therapeutics for the treatment of...
